Crossmark

Concomitant Use of Direct Oral Anticoagulants with Antiplatelet Agents and the Risk of Major Bleeding in Patients with Nonvalvular Atrial Fibrillation

Crossref DOI link: https://doi.org/10.1016/j.amjmed.2018.10.008

Published Print: 2019-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Douros, Antonios https://orcid.org/0000-0002-6005-4006
Renoux, Christel

Yin, Hui

Filion, Kristian B. https://orcid.org/0000-0001-6055-0088
Suissa, Samy

Azoulay, Laurent
Funding

Funding for this research was provided by:

Deutsche Forschungsgemeinschaft

McGill University

Fonds de Recherche du Québec - Santé

Bayer

Canada Foundation for Innovation
License Information

Text and Data Mining valid from 2019-02-01

Text and Data Mining valid from 2019-02-01
More Information

This article is maintained by: Elsevier

Article Title: Concomitant Use of Direct Oral Anticoagulants with Antiplatelet Agents and the Risk of Major Bleeding in Patients with Nonvalvular Atrial Fibrillation

Journal Title: The American Journal of Medicine

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.amjmed.2018.10.008

Content Type: article

Copyright: © 2018 Elsevier Inc. All rights reserved.

Document is current

Any future updates will be listed below